logo

FDA Calendar

Share
Company Name Seattle Genetics Inc.
Drug Name ADCETRIS (sBLA)
Event Name FDA decision on expanded use of ADCETRIS for the frontline treatment of advanced classical Hodgkin lymphoma
Event Date 05/01/2018
Outcome Date 03/20/2018
Outcome FDA approved ADCETRIS for expanded use on Mar.20, 2018
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar